Loading...
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
Since 1975, 191 patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (ChlVPP). Complete remission rates were 73% for previously untreated patients, 91% for patients previously treated with radiotherapy and 55% for patie...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group
1982
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2011032/ https://ncbi.nlm.nih.gov/pubmed/7093120 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|